Risk factors for pneumonitis in patients with non-small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective analysis.
Teppei YamaguchiJunichi ShimizuYuko OyaNaohiro WatanabeTakaaki HasegawaYoshitsugu HorioYoshitaka InabaYutaka FujiwaraPublished in: Thoracic cancer (2022)
Pre-existing ILD and pemetrexed exposure are risk factors for drug-induced pneumonitis in patients with NSCLC.